DLA Piper Dinu SCA
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
The life sciences sector and others subject to heavy regulatory scrutiny are the specialism of DLA Piper Dinu SCA's competition practice. Both merger control filings and assistance with industry investigations are covered by the group. Livia Zamfiropol draws on more than two decades of experience in leading the practice, handling antitrust investigations concerning anti-competitive agreements and alleged abuse of dominance. She coordinates the team with Alina Lacatus, who focuses on companies within the life sciences, FMCG and retail arenas. Razvan Pele is the main support contact to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Related to our collaboration, I would like to point out the expertise of the team, their flexibility and creativity to identify the best solutions and action ways accordingly with partner objectives. Not the last, it is important to mention the openness, availability and engagement of the team in the partnership.’
‘The team members involved in our collaboration were 100% at our disposal, giving us a strong filling of confidence and I would like to mention here Livia Zamfiropol and Alina Antonie.’
Key clients
- Takeda Pharmaceuticals International AG
- Zabka Polska Sp z o.o.
Work highlights
Acting for Takeda Pharmaceuticals International AG on matters including an annulment case pending before the Bucharest Court of Appeals, seeking the annulment of a substantial fine imposed by the Romanian Competition Council for alleged collusive behaviour by various immunoglobulin producers under the umbrella of the Plasma Protein Therapeutics Association (PPTA) in Romania.